Bank of Nova Scotia
BRLI

Bank of Nova Scotia’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bank of Nova Scotia’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,300
Closed -$383K – 718
2015
Q2 		$383K Hold
9,300
– – ﹤0.01% 423
2015
Q1 		$327K Buy
+9,300
New +$315K ﹤0.01% 464

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Bank of Nova Scotia's BRLI Position: Q3 2015 in Review

Bank of Nova Scotia sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 9,300 shares — an estimated $383K sold.

Bank of Nova Scotia first reported a position in BRLI in Q1 2015 and held it in 2 quarters. The position peaked at $383K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Bank of Nova Scotia reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Bank of Nova Scotia sold 9,300 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $383K.
  • Bank of Nova Scotia first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2015 and held it in 2 quarters.
  • Bank of Nova Scotia's BIO-REFERENCE LABS INC-NEW- position peaked at $383K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Bank of Nova Scotia's 13F filing for Q3 2015, filed 13 Nov 2015.